# A Mass Balance Study to Investigate the Absorption, Metabolism, and Excretion Of [14C] Fruquintinib

> **NCT02689752** · PHASE1 · COMPLETED · sponsor: **Hutchison Medipharma Limited** · enrollment: 6 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** fruquintinib

## Key facts

- **NCT ID:** NCT02689752
- **Lead sponsor:** Hutchison Medipharma Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07
- **Primary completion:** 2016-09
- **Final completion:** 2016-09
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2020-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02689752

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02689752, "A Mass Balance Study to Investigate the Absorption, Metabolism, and Excretion Of [14C] Fruquintinib". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02689752. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*